ExLibris header image
SFX Logo
Title: Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia
Source:

Blood [0006-4971] Eskazan, Ahmet yr:2016


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Soysal, T. "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia." Leukemia & lymphoma 55.12 (2014): 2935-7. Link to SFX for this item
2. Eskazan, Ahmet E. "Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpaşa experience." Journal of oncology pharmacy practice 22.2 (2015): 382-384. Link to Full Text for this item Link to SFX for this item
3. Botteman, M. "Assessment of Clinical Safety and Estimate of Survival in Iraqi Patients with Chronic Myeloid Leukemia Switched From Glivec (beta-Crystalline Form of Imatinib Mesylate) to an alpha-Crystalline Copy of Imatinib Mesylate." Blood 2012. 4439-4439. Link to SFX for this item
4. de Lemos, Mario L. "Clinical efficacy of generic imatinib." Journal of oncology pharmacy practice 21.1 (2014): 76-9. Link to Full Text for this item Link to SFX for this item
5. Sacha, T. "A multicenter prospective study on efficacy and safety of imatinib generics; a report from Polish Adult Leukemia Group imatinib generics registry." American journal of hematology 92.7. Link to SFX for this item
6. Fujisawa, S. "Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia." American journal of hematology 92.4 (2017): 367-374. Link to Full Text for this item Link to SFX for this item
7. "Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia." Clinical drug investigation 38.9: 837-844. Link to SFX for this item
8. Kaushik, A. "Diagnostic potential of 16 kDa (HspX, α-crystalline) antigen for serodiagnosis of tuberculosis." Indian Journal of Medical Research 135.5 (2012): 771-777. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.